191 related articles for article (PubMed ID: 19385008)
21. 18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells.
Qu Y; Chen WH; Zong L; Xu MY; Lu LG
Med Sci Monit; 2012 Jan; 18(1):BR24-32. PubMed ID: 22207106
[TBL] [Abstract][Full Text] [Related]
22. Resistin mediates the hepatic stellate cell phenotype.
Dong ZX; Su L; Brymora J; Bird C; Xie Q; George J; Wang JH
World J Gastroenterol; 2013 Jul; 19(28):4475-85. PubMed ID: 23901222
[TBL] [Abstract][Full Text] [Related]
23. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
24. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
25. Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.
Oh Y; Park O; Swierczewska M; Hamilton JP; Park JS; Kim TH; Lim SM; Eom H; Jo DG; Lee CE; Kechrid R; Mastorakos P; Zhang C; Hahn SK; Jeon OC; Byun Y; Kim K; Hanes J; Lee KC; Pomper MG; Gao B; Lee S
Hepatology; 2016 Jul; 64(1):209-23. PubMed ID: 26710118
[TBL] [Abstract][Full Text] [Related]
26. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic stellate cell (HSC) activation and liver fibrosis in C57BL6 mouse via activating Akt and NF-κB signaling pathways.
Han M; Liu X; Liu S; Su G; Fan X; Chen J; Yuan Q; Xu G
Toxicol Lett; 2017 May; 273():10-19. PubMed ID: 28302560
[TBL] [Abstract][Full Text] [Related]
27. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
[TBL] [Abstract][Full Text] [Related]
28. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
Borkham-Kamphorst E; Drews F; Weiskirchen R
Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
[TBL] [Abstract][Full Text] [Related]
29. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
30. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
[TBL] [Abstract][Full Text] [Related]
31. Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways.
Iizuka M; Murata T; Hori M; Ozaki H
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1010-21. PubMed ID: 21393429
[TBL] [Abstract][Full Text] [Related]
32. Graptopetalum paraguayense ameliorates chemical-induced rat hepatic fibrosis in vivo and inactivates stellate cells and Kupffer cells in vitro.
Su LJ; Chang CC; Yang CH; Hsieh SJ; Wu YC; Lai JM; Tseng TL; Huang CY; Hsu SL
PLoS One; 2013; 8(1):e53988. PubMed ID: 23335984
[TBL] [Abstract][Full Text] [Related]
33. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.
Planagumà A; Clària J; Miquel R; López-Parra M; Titos E; Masferrer JL; Arroyo V; Rodés J
FASEB J; 2005 Jul; 19(9):1120-2. PubMed ID: 15876570
[TBL] [Abstract][Full Text] [Related]
34. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.
Sui M; Jiang X; Chen J; Yang H; Zhu Y
Biomed Pharmacother; 2018 Oct; 106():125-133. PubMed ID: 29957462
[TBL] [Abstract][Full Text] [Related]
35. Altered aquaporin expression and role in apoptosis during hepatic stellate cell activation.
Lakner AM; Walling TL; McKillop IH; Schrum LW
Liver Int; 2011 Jan; 31(1):42-51. PubMed ID: 20958918
[TBL] [Abstract][Full Text] [Related]
36. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model.
Shim SG; Jun DW; Kim EK; Saeed WK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
J Gastroenterol Hepatol; 2013 Dec; 28(12):1877-84. PubMed ID: 23808892
[TBL] [Abstract][Full Text] [Related]
37. Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway.
Liang L; Yang X; Yu Y; Li X; Wu Y; Shi R; Jiang J; Gao L; Ye F; Zhao Q; Li R; Wei L; Han Z
Oncotarget; 2016 Dec; 7(50):82554-82566. PubMed ID: 27776340
[TBL] [Abstract][Full Text] [Related]
38. Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-κB and Akt.
Kim JK; Han NR; Park SM; Jegal KH; Jung JY; Jung EH; Kim EO; Kim D; Jung DH; Lee JR; Park CA; Ku SK; Cho IJ; Kim SC
Food Chem Toxicol; 2020 Jan; 135():111044. PubMed ID: 31830547
[TBL] [Abstract][Full Text] [Related]
39. Short interfering RNA targetting NF-kappa B induces apoptosis of hepatic stellate cells and attenuates extracellular matrix production.
Cui D; Zhang S; Ma J; Han J; Jiang H
Dig Liver Dis; 2010 Nov; 42(11):813-7. PubMed ID: 20409762
[TBL] [Abstract][Full Text] [Related]
40. Targeted elimination of activated hepatic stellate cells by an anti-epidermal growth factor-receptor single chain fragment variable antibody-tumor necrosis factor-related apoptosis-inducing ligand (scFv425-sTRAIL).
Arabpour M; Poelstra K; Helfrich W; Bremer E; Haisma HJ
J Gene Med; 2014; 16(9-10):281-90. PubMed ID: 25088657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
